Charles Schwab’s Fractyl Health GUTS Stock Holding History

Charles Schwab’s Portfolio GUTS Stock Details GUTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-80,664	Closed	-$96K	–	3593
2025 Q1	$96K	Hold	80,664	–	–	﹤0.01%	3348
2024 Q4	$166K	Hold	80,664	–	–	﹤0.01%	3347
2024 Q3	$204K	Buy	80,664 +29,262	+57%	+$95.5K	﹤0.01%	3335
2024 Q2	$219K	Buy	51,402 +17,813	+53%	+$115K	﹤0.01%	3428
2024 Q1	$249K	Buy	+33,589	New	+$283K	﹤0.01%	3206

Other funds holding GUTS

GCGM

General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return

DMC

Deer Management Company Larchmont, New York $622M AUM 24.27% 1-Year Est. Return

HCC Manager Chicago, Illinois $10.3M AUM 6.8% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Charles Schwab's GUTS Position: Q2 2025 in Review

Charles Schwab sold out of Fractyl Health (GUTS) in Q2 2025, closing a stake of 80,664 shares — an estimated $96K sold.

Charles Schwab first reported a position in GUTS in Q1 2024 and held it in 5 quarters. The position peaked at $249K in Q1 2024. 62 funds tracked by Wall St. Rank hold GUTS as of Q2 2025.

Charles Schwab reported no remaining Fractyl Health position as of Q2 2025 after selling out during the quarter.
Charles Schwab sold 80,664 Fractyl Health shares in Q2 2025, an estimated $96K.
Charles Schwab first reported a position in Fractyl Health in Q1 2024 and held it in 5 quarters.
Charles Schwab's Fractyl Health position peaked at $249K in Q1 2024.
62 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2025.

Based on Charles Schwab's 13F filing for Q2 2025, filed 12 Aug 2025.